Tuesday Capital
![](https://jumpaccelerator.com/wp-content/uploads/2024/06/output-onlinepngtools-12.png)
Tuesday Capital
San Francisco, California, United States
San Francisco, California
Stage
Early Stage, Private Equity, Seed, Venture
Type
Micro VC
Description
Tuesday Capital (formerly known as CrunchFund) is a seed stage focused venture firm that invests in information technology enabled companies. In 2019 CrunchFund was rebranded as Tuesday Capital.
Mission
For the last decade, Tuesday Capital (formerly CrunchFund) has helped Founders solve the world’s biggest problems. After dozens of Unicorns, IPOs and acquisitions, we are doubling down on our commitment to support our Founders throughout their many journeys building world-class companies from the ground up.
Beauty Investments #
1
Primary Sector
Tech/Consumer/Beauty
Beauty Exits #
- 0
Last Beauty Invest
Nov, 2022-Mother Science-$6.2M
BEAUTY PORTFOLIO
![](https://jumpaccelerator.com/wp-content/uploads/2024/06/u8fyrwoco5bvxaamgiek.webp)
How to Apply? | Contact Email partners@crunchfund.com |
Criteria |
Tuesday Capital maintains a variety of relationships with other VC firms and works alongside them, using its media and PR expertise, to help propel the companies of tomorrow. |
Resources Breakdown | Funding Terms |
|
Education |
|
|
Accelerator |
|
|
Network |
|
|
1:1 |
|
IMPERATIVE: CULTURE & VALUES
TBD
TBD
TBD
TBD
TBD
TBD
BEAUTY FUNDER FIT SCORE
Resources
Education
Accelerator
Network
1:1
2.75/10
*This score calculates the likelihood of any beauty brand getting funded by the investor. The score gives weights to number of beauty investments, recency of beauty investment, number of beauty exits, inclusivity inclination, resources offered, etc.
Inclusivity Investments % |
|
Beauty Investments # |
|
Beauty Exits # |
|
Last Beauty Invest |
|
LEAD DETAILS
Lead Contact
Patrick Gallagher
Title
Managing Partner
Email Id
Twitter Handle
JUMP CONCLUSION
![](/wp-content/uploads/2024/06/CONCLUSION.png)
Tuesday Capital focuses on early-stage ventures, primarily in the seed phase, with a tech-centric approach, notably in AI, IT, Health Care & bio-tech, suggests a diversified portfolio strategy.